Sequence Bio
YC S19St. John's, CA · Founded 2013 · 52 employees · 2 known investors
Sequence Bio discovers genetic causes of disease within Newfoundland and Labrador's founder population to develop breakthrough treatments, diagnostics, and preventions. The company focuses on translational biology and genetics research for patients globally.
AI & Machine LearningBiotechDeep TechHealthtechGenomicsTherapeuticsDrug discoveryin /sequencebioinformatics@sequencebio
Founders & leadership· Y Combinator alumni (S19)
Jeremy Grushcowin𝕏Founder
Chris GardnerinFounder
LH
Lynn HealeyChief Executive Officer
TB
Tom BarberChief Scientific Officer